Senior insider sale
TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$310.7K
5K shares
What this filing means
LYONS GARY A plans to sell 5K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $310.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001950047-26-008242
5K
Shares to sell
$310.7K
Approx. market value
5K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/17/2026
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Exercise of Stock Options Cash | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5K
Market value
$310.7K
8/17/2026
Total
Units
5K
Value
$310.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 5K | $310.7K | NASDAQ | Planned |
| Total | 5K | $310.7K | ||